Systems genomics support for immune and inflammation hypothesis of depression

Current Neuropharmacology

Volumn 14, Issue 7, 2016, Pages 749-758

  Sharma, Abhay ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Antidepressant; Depression; Genome wide association; Immune; Inflammation; Proteomic; Transcriptomic

Indexed keywords

APOLIPOPROTEIN E; TRANSCRIPTOME;

ADAPTIVE IMMUNITY; BRAIN REGION; DEPRESSION; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOMICS; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; UPREGULATION; ANIMAL; GENETICS; GENOME; HUMAN; IMMUNOLOGY; METABOLISM; PROCEDURES; PSYCHOLOGY;

ANIMALS; DEPRESSIVE DISORDER; GENOME; GENOMICS; HUMANS; INFLAMMATION; PROTEOMICS; TRANSCRIPTOME;

EID: 84986921946     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X14666160106155331     Document Type: Review

References (63)

1. Yirmiya, R.; Goshen, I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun., 2011, 25(2), 181-213. [http://dx.doi.org/10.1016/j.bbi.2010.10.015] [PMID: 20970492]
2. Maes, M.; Bosmans, E.; Suy, E.; Vandervorst, C.; Dejonckheere, C.; Raus, J. Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. J. Affect. Disord., 1991, 21(2), 133-140. [http://dx.doi.org/10.1016/0165-0327(91)90060-6] [PMID: 1851504]
3. Maes, M.; Bosmans, E.; Suy, E.; Vandervorst, C.; DeJonckheere, C.; Raus, J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr. Scand., 1991, 84(4), 379-386. [http://dx.doi.org/10.1111/j.1600-0447.1991.tb03163.x] [PMID: 1746291]
4. Maes, M. A review on citation amnesia in depression and inflammation research. Neuroendocrinol. Lett., 2015, 36(1), 1-6. [PMID: 25789583]
5. Maes, M.; Meltzer, H.Y.; Bosmans, E.; Bergmans, R.; Vandoolaeghe, E.; Ranjan, R.; Desnyder, R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord., 1995, 34(4), 301-309. [http://dx.doi.org/10.1016/0165-0327(95)00028-L] [PMID: 8550956]
6. McNamara, R.K.; Lotrich, F.E. Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev. Neurother., 2012, 12(9), 1143-1161. [http://dx.doi.org/10.1586/ern.12.98] [PMID: 23039393]
7. Hurley, L.L.; Tizabi, Y. Neuroinflammation, neurodegeneration, and depression. Neurotox. Res., 2013, 23(2), 131-144. [http://dx.doi.org/10.1007/s12640-012-9348-1] [PMID: 22895696]
8. Patel, A. Review: the role of inflammation in depression. Psychiatr. Danub., 2013, 25(Suppl 2), S216-S223. [PMID: 23995180]
9. Rosenblat, J.D.; Cha, D.S.; Mansur, R.B.; McIntyre, R.S. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2014, 53, 23-34. [http://dx.doi.org/10.1016/j.pnpbp.2014.01.013] [PMID: 24468642]
10. Müller, N. Immunology of major depression. Neuroimmunomodulation, 2014, 21(2-3), 123-130. [PMID: 24557045]
11. Allison, D.J.; Ditor, D.S. The common inflammatory etiology of depression and cognitive impairment: a therapeutic target. J. Neuroinflammation, 2014, 11, 151. [http://dx.doi.org/10.1186/s12974-014-0151-1] [PMID: 25178630]
12. Liu, J.; Buisman-Pijlman, F.; Hutchinson, M.R. Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder. Front. Neurosci., 2014, 8, 309. [http://dx.doi.org/10.3389/fnins.2014.00309] [PMID: 25324715]
13. Bakunina, N.; Pariante, C.M.; Zunszain, P.A. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology, 2015, [http://dx.doi.org/10.1111/imm.12443] [PMID: 25580634]
14. Horowitz, M.A.; Zunszain, P.A. Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin. Ann. N. Y. Acad. Sci., 2015, 1351, 68-79. [http://dx.doi.org/10.1111/nyas. 12781] [PMID: 25943397]
15. Felger, J.C.; Lotrich, F.E. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience, 2013, 246, 199-229. [http://dx.doi.org/10.1016/j. neuroscience.2013.04.060] [PMID: 23644052]
16. Kao, C.F.; Jia, P.; Zhao, Z.; Kuo, P.H. Enriched pathways for major depressive disorder identified from a genome-wide association study. Int. J. Neuropsychopharmacol., 2012, 15(10), 1401-1411. [http://dx.doi.org/10.1017/S1461145711001891] [PMID: 22243633]
17. Bufalino, C.; Hepgul, N.; Aguglia, E.; Pariante, C.M. The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain Behav. Immun., 2013, 31, 31-47. [http://dx.doi.org/10.1016/j.bbi.2012.04. 009] [PMID: 22580182]
18. Raison, C.L.; Miller, A.H. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol. Psychiatry, 2013, 18(1), 15-37. [http://dx.doi.org/10.1038/mp. 2012.2] [PMID: 22290120]
19. Flint, J.; Kendler, K.S. The genetics of major depression. Neuron, 2014, 81(3), 484-503. [http://dx.doi.org/10.1016/j.neuron.2014.01. 027] [PMID: 24507187]
20. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci., 2015, 18(2), 199-209. [http://dx.doi.org/10.1038/nn.3922] [PMID: 25599223]
21. The Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucl. Acids Res., 2015, 43(Database issue), D1049-D1056.
22. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature, 2015, 523(7562), 588-591. [http://dx.doi.org/10.1038/nature14659] [PMID: 26176920]
23. Aston, C.; Jiang, L.; Sokolov, B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol. Psychiatry, 2005, 10(3), 309-322. [http://dx.doi.org/10.1038/sj.mp.4001565] [PMID: 15303102]
24. Choudary, P.V.; Molnar, M.; Evans, S.J.; Tomita, H.; Li, J.Z.; Vawter, M.P.; Myers, R.M.; Bunney, W.E., Jr.; Akil, H.; Watson, S.J.; Jones, E.G. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. USA, 2005, 102(43), 15653-15658. [http://dx.doi.org/10.1073/pnas.0507901102] [PMID: 16230605]
25. Sequeira, A.; Gwadry, F.G.; Ffrench-Mullen, J.M.; Canetti, L.; Gingras, Y.; Casero, R.A., Jr; Rouleau, G.; Benkelfat, C.; Turecki, G. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch. Gen. Psychiatry, 2006, 63(1), 35-48. [http://dx.doi.org/10.1001/archpsyc.63.1.35] [PMID: 16389195]
26. Kang, H.J.; Adams, D.H.; Simen, A.; Simen, B.B.; Rajkowska, G.; Stockmeier, C.A.; Overholser, J.C.; Meltzer, H.Y.; Jurjus, G.J.; Konick, L.C.; Newton, S.S.; Duman, R.S. Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J. Neurosci., 2007, 27(48), 13329-13340. [http://dx.doi.org/10.1523/JNEUROSCI.4083-07.2007] [PMID: 18045927]
27. Sequeira, A.; Klempan, T.; Canetti, L.; ffrench-Mullen, J.; Benkelfat, C.; Rouleau, G.A.; Turecki, G. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol. Psychiatry, 2007, 12(7), 640-655. [http://dx.doi.org/10.1038/sj.mp.4001969] [PMID: 17353912]
28. Tochigi, M.; Iwamoto, K.; Bundo, M.; Sasaki, T.; Kato, N.; Kato, T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci. Res., 2008, 60(2), 184-191. [http://dx.doi.org/10.1016/j.neures.2007.10.010] [PMID: 18068248]
29. Chu, T.T.; Liu, Y.; Kemether, E. Thalamic transcriptome screening in three psychiatric states. J. Hum. Genet., 2009, 54(11), 665-675. [http://dx.doi.org/10.1038/jhg.2009.93] [PMID: 19834500]
30. Lalovic, A.; Klempan, T.; Sequeira, A.; Luheshi, G.; Turecki, G. Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers. J. Affect. Disord., 2010, 120(1-3), 24-31. [http://dx.doi.org/10.1016/j.jad.2009.04.007] [PMID: 19443042]
31. Bernard, R.; Kerman, I.A.; Thompson, R.C.; Jones, E.G.; Bunney, W.E.; Barchas, J.D.; Schatzberg, A.F.; Myers, R.M.; Akil, H.; Watson, S.J. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol. Psychiatry, 2011, 16(6), 634-646. [http://dx.doi.org/10.1038/mp.2010.44] [PMID: 20386568]
32. Shelton, R.C.; Claiborne, J.; Sidoryk-Wegrzynowicz, M.; Reddy, R.; Aschner, M.; Lewis, D.A.; Mirnics, K. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol. Psychiatry, 2011, 16(7), 751-762. [http://dx.doi.org/10.1038/mp.2010.52] [PMID: 20479761]
33. Kerman, I.A.; Bernard, R.; Bunney, W.E.; Jones, E.G.; Schatzberg, A.F.; Myers, R.M.; Barchas, J.D.; Akil, H.; Watson, S.J.; Thompson, R.C. Evidence for transcriptional factor dysregulation in the dorsal raphe nucleus of patients with major depressive disorder. Front. Neurosci., 2012, 6, 135. [http://dx.doi.org/10.3389/fnins.2012.00135] [PMID: 23087602]
34. Duric, V.; Banasr, M.; Stockmeier, C.A.; Simen, A.A.; Newton, S.S.; Overholser, J.C.; Jurjus, G.J.; Dieter, L.; Duman, R.S. Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int. J. Neuropsychopharmacol., 2013, 16(1), 69-82. [http://dx.doi.org/10.1017/S1461145712000016] [PMID: 22339950]
35. Kim, S.; Hwang, Y.; Webster, M.J.; Lee, D. Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders. Mol. Psychiatry, 2015, [http://dx.doi.org/10.1038/mp.2015.79] [PMID: 26077692]
36. Beasley, C.L.; Pennington, K.; Behan, A.; Wait, R.; Dunn, M.J.; Cotter, D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics, 2006, 6(11), 3414-3425. [http://dx.doi.org/10.1002/pmic.200500069] [PMID: 16637010]
37. Ditzen, C.; Tang, N.; Jastorff, A.M.; Teplytska, L.; Yassouridis, A.; Maccarrone, G.; Uhr, M.; Bronisch, T.; Miller, C.A.; Holsboer, F.; Turck, C.W. Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology, 2012, 37(4), 1013-1025. [http://dx.doi.org/10.1038/npp.2011.285] [PMID: 22169944]
38. Martins-de-Souza, D.; Guest, P.C.; Vanattou-Saifoudine, N.; Rahmoune, H.; Bahn, S. Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function. Eur. Arch. Psychiatry Clin. Neurosci., 2012, 262(8), 657-666. [http://dx.doi.org/10.1007/s00406-012-0301-3] [PMID: 22350622]
39. Martins-de-Souza, D.; Guest, P.C.; Harris, L.W.; Vanattou-Saifoudine, N.; Webster, M.J.; Rahmoune, H.; Bahn, S. Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients. Transl. Psychiatry, 2012, 2, e87. [http://dx.doi.org/10.1038/tp.2012.13] [PMID: 22832852]
40. Böhm, C.; Newrzella, D.; Herberger, S.; Schramm, N.; Eisenhardt, G.; Schenk, V.; Sonntag-Buck, V.; Sorgenfrei, O. Effects of antidepressant treatment on gene expression profile in mouse brain: cell type-specific transcription profiling using laser microdissection and microarray analysis. J. Neurochem., 2006, 97(Suppl 1), 44-49. [http://dx.doi.org/10.1111/j.1471-4159.2006.03750.x] [PMID: 16635249]
41. Lee, J.H.; Ko, E.; Kim, Y.E.; Min, J.Y.; Liu, J.; Kim, Y.; Shin, M.; Hong, M.; Bae, H. Gene expression profile analysis of genes in rat hippocampus from antidepressant treated rats using DNA microarray. BMC Neurosci., 2010, 11, 152. [http://dx.doi.org/10.1186/1471-2202-11-152] [PMID: 21118505]
42. Lisowski, P.; Juszczak, G.R.; Goscik, J.; Stankiewicz, A.M.; Wieczorek, M.; Zwierzchowski, L.; Swiergiel, A.H. Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice. BMC Neurosci., 2013, 14, 144. [http://dx.doi.org/10.1186/1471-2202-14-144] [PMID: 24225037]
43. Palotás, M.; Palotás, A.; Puskás, L.G.; Kitajka, K.; Pákáski, M.; Janka, Z.; Molnár, J.; Penke, B.; Kálmán, J. Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram. Int. J. Neuropsychopharmacol., 2004, 7(4), 401-413. [http://dx.doi.org/10.1017/S1461145704004493] [PMID: 15315716]
44. Sillaber, I.; Panhuysen, M.; Henniger, M.S.; Ohl, F.; Kühne, C.; Pütz, B.; Pohl, T.; Deussing, J.M.; Paez-Pereda, M.; Holsboer, F. Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology (Berl.), 2008, 200(4), 557-572. [Berl]. [http://dx.doi.org/10.1007/s00213-008-1232-6] [PMID: 18629477]
45. Takahashi, K.; Saitoh, A.; Yamada, M.; Maruyama, Y.; Hirose, N.; Kamei, J.; Yamada, M. Gene expression profiling reveals complex changes in the olfactory bulbectomy model of depression after chronic treatment with antidepressants. J. Pharmacol. Sci., 2008, 108(3), 320-334. [http://dx.doi.org/10.1254/jphs.08149FP] [PMID: 19023179]
46. Kroes, R.A.; Panksepp, J.; Burgdorf, J.; Otto, N.J.; Moskal, J.R. Modeling depression: social dominance-submission gene expression patterns in rat neocortex. Neuroscience, 2006, 137(1), 37-49. [http://dx.doi.org/10.1016/j.neuroscience.2005.08.076] [PMID: 16289586]
47. Kanarik, M.; Alttoa, A.; Matrov, D.; Kõiv, K.; Sharp, T.; Panksepp, J.; Harro, J. Brain responses to chronic social defeat stress: effects on regional oxidative metabolism as a function of a hedonic trait, and gene expression in susceptible and resilient rats. Eur. Neuropsychopharmacol., 2011, 21(1), 92-107. [http://dx.doi.org/10.1016/j.euroneuro.2010.06.015] [PMID: 20656462]
48. Berton, O.; McClung, C.A.; Dileone, R.J.; Krishnan, V.; Renthal, W.; Russo, S.J.; Graham, D.; Tsankova, N.M.; Bolanos, C.A.; Rios, M.; Monteggia, L.M.; Self, D.W.; Nestler, E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science, 2006, 311(5762), 864-868. [http://dx.doi.org/10.1126/science.1120972] [PMID: 16469931]
49. Azzinnari, D.; Sigrist, H.; Staehli, S.; Palme, R.; Hildebrandt, T.; Leparc, G.; Hengerer, B.; Seifritz, E.; Pryce, C.R. Mouse social stress induces increased fear conditioning, helplessness and fatigue to physical challenge together with markers of altered immune and dopamine function. Neuropharmacology, 2014, 85, 328-341. [http://dx.doi.org/10.1016/j.neuropharm.2014.05.039] [PMID: 24907589]
50. National Center for Biotechnology Information. BioSystems. http://www.ncbi.nlm.nih.gov/biosystems/, [Accessed August 31, 2015];
51. Galeotti, N.; Vivoli, E.; Norcini, M.; Bartolini, A.; Ghelardini, C. An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. Neuropharmacology, 2008, 55(7), 1156-1164. [http://dx.doi.org/10.1016/j.neuropharm. 2008.07.029] [PMID: 18708078]
52. Song, G.G.; Kim, J.H.; Lee, Y.H. Genome-wide pathway analysis in major depressive disorder. J. Mol. Neurosci., 2013, 51(2), 428-436. [http://dx.doi.org/10.1007/s12031-013-0047-z] [PMID: 23794217]
53. Lotan, A.; Fenckova, M.; Bralten, J.; Alttoa, A.; Dixson, L.; Williams, R.W.; van der Voet, M. Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders. Front. Neurosci., 2014, 8, 331. [http://dx.doi.org/10.3389/fnins.2014.00331] [PMID: 25414627]
54. Gao, L.; Gao, Y.; Xu, E.; Xie, J. Microarray Analysis of the Major Depressive Disorder mRNA Profile Data. Psychiatry Investig., 2015, 12(3), 388-396. [http://dx.doi.org/10.4306/pi.2015.12.3.388] [PMID: 26207134]
55. Jansen, R.; Penninx, B.W.; Madar, V.; Xia, K.; Milaneschi, Y.; Hottenga, J.J.; Hammerschlag, A.R.; Beekman, A.; van der Wee, N.; Smit, J.H.; Brooks, A.I.; Tischfield, J.; Posthuma, D.; Schoevers, R.; van Grootheest, G.; Willemsen, G.; de Geus, E.J.; Boomsma, D.I.; Wright, F.A.; Zou, F.; Sun, W.; Sullivan, P.F. Gene expression in major depressive disorder. Mol. Psychiatry, 2015, ••• [http://dx.doi.org/10.1038/mp.2015.57]
56. Elovainio, M.; Taipale, T.; Seppälä, I.; Mononen, N.; Raitoharju, E.; Jokela, M.; Pulkki-Råback, L.; Illig, T.; Waldenberger, M.; Hakulinen, C.; Hintsa, T.; Kivimäki, M.; Kähönen, M.; Keltikangas-Järvinen, L.; Raitakari, O.; Lehtimäki, T. Activated immune-inflammatory pathways are associated with long-standing depressive symptoms: Evidence from gene-set enrichment analyses in the Young Finns Study. J. Psychiatr. Res., 2015, 71, 120-125. [http://dx.doi.org/10.1016/j.jpsychires.2015.09.017] [PMID: 26473696]
57. Bot, M.; Chan, M.K.; Jansen, R.; Lamers, F.; Vogelzangs, N.; Steiner, J.; Leweke, F.M.; Rothermundt, M.; Cooper, J.; Bahn, S.; Penninx, B.W. Serum proteomic profiling of major depressive disorder. Transl. Psychiatry, 2015, 5, e599. [http://dx.doi.org/10.1038/tp.2015.88] [PMID: 26171980]
58. Lee, J.; Joo, E.J.; Lim, H.J.; Park, J.M.; Lee, K.Y.; Park, A.; Seok, A.; Lee, H.; Kang, H.G. Proteomic analysis of serum from patients with major depressive disorder to compare their depressive and remission statuses. Psychiatry Investig., 2015, 12(2), 249-259. [http://dx.doi.org/10.4306/pi.2015.12.2.249] [PMID: 25866527]
59. Stelzhammer, V.; Haenisch, F.; Chan, M.K.; Cooper, J.D.; Steiner, J.; Steeb, H.; Martins-de-Souza, D.; Rahmoune, H.; Guest, P.C.; Bahn, S. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients. Int. J. Neuropsychopharmacol., 2014, 17(10), 1599-1608. [http://dx.doi.org/10.1017/S1461145714000819] [PMID: 24901538]
60. Xu, H.B.; Zhang, R.F.; Luo, D.; Zhou, Y.; Wang, Y.; Fang, L.; Li, W.J.; Mu, J.; Zhang, L.; Zhang, Y.; Xie, P. Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation. Int. J. Neuropsychopharmacol., 2012, 15(10), 1413-1425. [http://dx.doi.org/10.1017/S1461145712000302] [PMID: 22717272]
61. Devorak, J.; Torres-Platas, S.G.; Davoli, M.A.; Prud’homme, J.; Turecki, G.; Mechawar, N. Cellular and Molecular Inflammatory Profile of the Choroid Plexus in Depression and Suicide. Front. Psychiatry, 2015, 6, 138. [http://dx.doi.org/10.3389/fpsyt.2015. 00138] [PMID: 26539126]
62. Maes, M.; Nowak, G.; Caso, J.R.; Leza, J.C.; Song, C.; Kubera, M.; Klein, H.; Galecki, P.; Noto, C.; Glaab, E.; Balling, R.; Berk, M. Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research. Mol. Neurobiol., 2015, [http://dx.doi.org/10.1007/s12035-015-9183-5] [PMID: 25934103]
63. Hodes, G.E.; Kana, V.; Menard, C.; Merad, M.; Russo, S.J. Neuroimmune mechanisms of depression. Nat. Neurosci., 2015, 18(10), 1386-1393. [http://dx.doi.org/10.1038/nn.4113] [PMID: 26404713]